Search Results

Transforming clinical trials.

Subjects: *CLINICAL trials

• Source: New Scientist. 3/9/2024, Vol. 261 Issue 3481, p26-27. 2p. 3 Color Photographs.

Record details

Diversity in Clinical Trials: Strategies and Challenges: Why weighing all of the ‘DE&I’ components is critical at site and sponsor levels.

• Authors : Harper, Jamie¹

Subjects: *CLINICAL trials; *MEDICAL personnel

• Source: Applied Clinical Trials. Mar2024, Vol. 33 Issue 3, p22-23. 2p.

Record details

Streamlining clinical trials: overcoming the diagnostics challenge.

• Authors : Nicholls, Mark (AUTHOR)

Subjects: *CLINICAL trials; *WEARABLE technology; *VITAL signs

• Source: New Scientist. 12/16/2023, Vol. 260 Issue 3469/70, p31-31. 1/2p. 2 Color Photographs.

Record details

Funding is associated with increased methodological and statistical reporting in onychomycosis randomised controlled/comparative clinical trials.

• Authors : M. Falotico, Julianne (AUTHOR); D. Desai, Amar¹ (AUTHOR); R. Lipner, Shari² (AUTHOR)

Subjects: *ONYCHOMYCOSIS; *CLINICAL trial registries; *CLINICAL trials

• Source: Indian Journal of Dermatology, Venereology & Leprology. Jan/Feb2024, Vol. 90 Issue 1, p1-3. 3p.

Record details

eCOA FLEXIBILITY IN CLINICAL TRIALS: THE SITE PERSPECTIVE.

Subjects: *CLINICAL trials; *HEALTH outcome assessment; *PATIENT compliance

• Source: Applied Clinical Trials. Jan/Feb2024, Vol. 33 Issue 1/2, p10-11. 2p.

Record details

AI’S FUTURE IN CLINICAL TRIALS: BRIDGING THE INNOVATION-ACCESS GAP.

• Authors : Verma, Seema¹

Subjects: *CLINICAL trials; *GENERATIVE artificial intelligence; *CLINICAL trial registries

• Source: Applied Clinical Trials. Jan/Feb2024, Vol. 33 Issue 1/2, p8-9. 2p.

Record details

Industry's role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials.

• Authors : Anwar, Tahsin¹ (AUTHOR) ; Malhotra, Sean² (AUTHOR); Mian, Mohammad A. H.^3,4 (AUTHOR)

Subjects: *HEPATITIS B; *HEPATITIS C; *CLINICAL trials

• Source: Hematology. Dec2023, Vol. 28 Issue 1, p1-4. 4p.

Record details

The future of decentralized clinical trials in ophthalmology: Research can drive opportunities for patients with rare diseases.

• Authors : Magrath, George¹; Posvar, Winston; Pucker, Andrew²

Subjects: *TREATMENT of rare diseases; *CLINICAL trials; *PATIENT satisfactionUNITED States. Food & Drug Administration

• Source: Ophthalmology Times. Dec2023, Vol. 48 Issue 12, p27-31. 3p.

Record details

The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17.

• Authors : Lyden, Patrick¹ (AUTHOR) ; Broderick, Joseph² (AUTHOR); Grotta, James³ (AUTHOR)

Subjects: *ISCHEMIC stroke; *CLINICAL trials; *MEDICAL research

• Source: BMC Medical Research Methodology. 11/21/2023, Vol. 23 Issue 1, p1-3. 3p.

Record details

Streamlining Clinical Trials: Mitigation and Management: How service providers are helping to accelerate drug development.

• Authors : Gray, Scott¹

Subjects: *CLINICAL trials; *DRUG development; *DISRUPTIVE innovations

• Source: Applied Clinical Trials. Nov2023, Vol. 32 Issue 11, p18-19. 2p.

Record details